BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 18460583)

  • 1. UV-induced degradation of securin is mediated by SKP1-CUL1-beta TrCP E3 ubiquitin ligase.
    Limón-Mortés MC; Mora-Santos M; Espina A; Pintor-Toro JA; López-Román A; Tortolero M; Romero F
    J Cell Sci; 2008 Jun; 121(11):1825-31. PubMed ID: 18460583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein phosphatase 2A stabilizes human securin, whose phosphorylated forms are degraded via the SCF ubiquitin ligase.
    Gil-Bernabé AM; Romero F; Limón-Mortés MC; Tortolero M
    Mol Cell Biol; 2006 Jun; 26(11):4017-27. PubMed ID: 16705156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3beta (GSK3beta) negatively regulates PTTG1/human securin protein stability, and GSK3beta inactivation correlates with securin accumulation in breast tumors.
    Mora-Santos M; Limón-Mortés MC; Giráldez S; Herrero-Ruiz J; Sáez C; Japón MÁ; Tortolero M; Romero F
    J Biol Chem; 2011 Aug; 286(34):30047-56. PubMed ID: 21757741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells.
    Wei S; Yang HC; Chuang HC; Yang J; Kulp SK; Lu PJ; Lai MD; Chen CS
    J Biol Chem; 2008 Sep; 283(39):26759-70. PubMed ID: 18650423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. βTrCP-mediated ubiquitylation regulates protein stability of Mis18β in a cell cycle-dependent manner.
    Kim IS; Lee M; Park JH; Jeon R; Baek SH; Kim KI
    Biochem Biophys Res Commun; 2014 Jan; 443(1):62-7. PubMed ID: 24269809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation.
    Wu K; Fuchs SY; Chen A; Tan P; Gomez C; Ronai Z; Pan ZQ
    Mol Cell Biol; 2000 Feb; 20(4):1382-93. PubMed ID: 10648623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
    Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skp1-Cul1-F-box ubiquitin ligase (SCF(βTrCP))-mediated destruction of the ubiquitin-specific protease USP37 during G2-phase promotes mitotic entry.
    Burrows AC; Prokop J; Summers MK
    J Biol Chem; 2012 Nov; 287(46):39021-9. PubMed ID: 23027877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR.
    Kainulainen M; Lau S; Samuel CE; Hornung V; Weber F
    J Virol; 2016 Jul; 90(13):6140-7. PubMed ID: 27122577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.
    Watanabe N; Arai H; Nishihara Y; Taniguchi M; Watanabe N; Hunter T; Osada H
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4419-24. PubMed ID: 15070733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS impairs phospholipid synthesis by triggering beta-transducin repeat-containing protein (beta-TrCP)-mediated polyubiquitination and degradation of the surfactant enzyme acyl-CoA:lysophosphatidylcholine acyltransferase I (LPCAT1).
    Zou C; Butler PL; Coon TA; Smith RM; Hammen G; Zhao Y; Chen BB; Mallampalli RK
    J Biol Chem; 2011 Jan; 286(4):2719-27. PubMed ID: 21068446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing βTrCP.
    Sasajima H; Nakagawa K; Kashiwayanagi M; Yokosawa H
    Biol Pharm Bull; 2012; 35(9):1539-45. PubMed ID: 22975506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex.
    Wei W; Ayad NG; Wan Y; Zhang GJ; Kirschner MW; Kaelin WG
    Nature; 2004 Mar; 428(6979):194-8. PubMed ID: 15014503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
    Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
    Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.
    Low TY; Peng M; Magliozzi R; Mohammed S; Guardavaccaro D; Heck AJ
    Sci Signal; 2014 Dec; 7(356):rs8. PubMed ID: 25515538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smurf1 targets Securin for ubiquitin-dependent degradation and regulates the metaphase-to-anaphase transition.
    Wei R; Li B; Guo J; Li M; Zhu R; Yang X; Gao R
    Cell Signal; 2017 Oct; 38():60-66. PubMed ID: 28658604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin E3 ligase SCF(β-TRCP) regulates TRIB2 stability in liver cancer cells.
    Qiao Y; Zhang Y; Wang J
    Biochem Biophys Res Commun; 2013 Nov; 441(3):555-9. PubMed ID: 24211582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts.
    Wirbelauer C; Sutterlüty H; Blondel M; Gstaiger M; Peter M; Reymond F; Krek W
    EMBO J; 2000 Oct; 19(20):5362-75. PubMed ID: 11032804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation.
    Yang L; Wang N; Tang Y; Cao X; Wan M
    Hum Mutat; 2006 Sep; 27(9):897-905. PubMed ID: 16865698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.